These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17133844)

  • 1. Nitric oxide synthase inhibitors in post-myocardial infarction cardiogenic shock--an update.
    Kaluski E; Hendler A; Blatt A; Uriel N
    Clin Cardiol; 2006 Nov; 29(11):482-8. PubMed ID: 17133844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm.
    Hochman JS
    Circulation; 2003 Jun; 107(24):2998-3002. PubMed ID: 12821585
    [No Abstract]   [Full Text] [Related]  

  • 3. LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study.
    Cotter G; Kaluski E; Milo O; Blatt A; Salah A; Hendler A; Krakover R; Golick A; Vered Z
    Eur Heart J; 2003 Jul; 24(14):1287-95. PubMed ID: 12871685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiogenic shock: have we really found the magic potion?
    Menon V
    Eur Heart J; 2003 Jul; 24(14):1279-81. PubMed ID: 12871682
    [No Abstract]   [Full Text] [Related]  

  • 5. Tilarginine in patients with acute myocardial infarction and cardiogenic shock.
    Teerlink T
    JAMA; 2007 Sep; 298(9):971-2; author reply 972-3. PubMed ID: 17785640
    [No Abstract]   [Full Text] [Related]  

  • 6. Tilarginine in patients with acute myocardial infarction and cardiogenic shock.
    Kielstein JT; Sydow K; Thum T
    JAMA; 2007 Sep; 298(9):971; author reply 972-3. PubMed ID: 17785641
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiogenic shock: the role of inflammation.
    Shpektor A
    Acute Card Care; 2010 Dec; 12(4):115-8. PubMed ID: 21039083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial.
    ; Alexander JH; Reynolds HR; Stebbins AL; Dzavik V; Harrington RA; Van de Werf F; Hochman JS
    JAMA; 2007 Apr; 297(15):1657-66. PubMed ID: 17387132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shock in acute myocardial infarction: the Cape Horn for trials?
    Thiele H; Allam B; Chatellier G; Schuler G; Lafont A
    Eur Heart J; 2010 Aug; 31(15):1828-35. PubMed ID: 20610640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies.
    Kilbourn RG; Szabó C; Traber DL
    Shock; 1997 Apr; 7(4):235-46. PubMed ID: 9110408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study.
    Dzavík V; Cotter G; Reynolds HR; Alexander JH; Ramanathan K; Stebbins AL; Hathaway D; Farkouh ME; Ohman EM; Baran DA; Prondzinsky R; Panza JA; Cantor WJ; Vered Z; Buller CE; Kleiman NS; Webb JG; Holmes DR; Parrillo JE; Hazen SL; Gross SS; Harrington RA; Hochman JS;
    Eur Heart J; 2007 May; 28(9):1109-16. PubMed ID: 17459901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiogenic shock: basics and clinical considerations.
    Gowda RM; Fox JT; Khan IA
    Int J Cardiol; 2008 Jan; 123(3):221-8. PubMed ID: 18037513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expert opinion on tilarginine in the treatment of shock.
    Howes LG; Brillante DG
    Expert Opin Investig Drugs; 2008 Oct; 17(10):1573-80. PubMed ID: 18808317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide in the pathogenesis of sepsis.
    Symeonides S; Balk RA
    Infect Dis Clin North Am; 1999 Jun; 13(2):449-63, x. PubMed ID: 10340177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiogenic shock complicating acute myocardial infarction in elderly patients: does admission to a tertiary center improve survival?
    Berger AK; Radford MJ; Krumholz HM
    Am Heart J; 2002 May; 143(5):768-76. PubMed ID: 12040336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of nitric oxide synthesis in sepsis: a promising strategy?
    Hollenberg SM
    Crit Care Med; 1998 Apr; 26(4):638-9. PubMed ID: 9559596
    [No Abstract]   [Full Text] [Related]  

  • 17. Intervention with nitric oxide synthase inhibitors for traumatic shock in rats.
    Sun GB; Huang ZH; Sun YG; Yang WY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):306-9. PubMed ID: 12697459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary coronary angioplasty versus thrombolysis for acute myocardial infarction.
    French JK; Canborn TA; Sleeper LA
    Lancet; 2003 Apr; 361(9365):1303-4; author reply 1304-5. PubMed ID: 12699988
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of nitric oxide synthase inhibitors on the febrile response to lipopolysaccharide and muramyl dipeptide in guinea pigs.
    Kamerman P; Fuller A
    Life Sci; 2000 Oct; 67(21):2639-45. PubMed ID: 11104365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of benefit from nitric oxide synthase inhibition in patients with cardiogenic shock: looking for the reasons.
    Ndrepepa G; Schömig A; Kastrati A
    JAMA; 2007 Apr; 297(15):1711-3. PubMed ID: 17440148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.